Discovery, Biological Evaluation, and Structure–Activity and −Selectivity Relationships of 6′-Substituted (<i>E</i>)-2-(Benzofuran-3(2<i>H</i>)-ylidene)-<i>N</i>-methylacetamides, a Novel Class of Potent and Selective Monoamine Oxidase Inhibitors
The use of selective inhibitors of monoamineoxidase A (MAO-A) and B (MAO-B) holds a therapeutic relevance in the treatment of depressive disorders and Parkinson’s disease (PD), respectively. Here, the discovery of a newclass of compounds acting as monoamineoxidaseinhibitors (MAO-Is) and bearing a 6′-substituted (E)-2-(benzofuran-3(2H)-ylidene)-N-alkylacetamide skeleton is reported. 6′-Sulfonyloxy